EMEA-002489-PIP02-24
Published 20 hours ago• 1 minute read
Active Substance
rivoceranib
Therapeutic area
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Decision number
P/0191/2024
PIP number
EMEA-002489-PIP02-24
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of hepatocellular carcinoma
Route(s) of administration
Oral use
Contact for public enquiries
Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Loading...
Loading...
You may also like...
Loading...
